REG - GlaxoSmithKline PLC - Block listing Interim Review

GSKAnnouncement

18/05/2021 13:55

RNS Number : 0302Z
  
GlaxoSmithKline PLC
  
18 May 2021
  
 

 
 
 
BLOCK LISTING SIX MONTHLY RETURN
 
 
Date: 18 May 2021
 




Name of applicant:


GlaxoSmithKline plc




Name of scheme:


GlaxoSmithKline plc 2017 Deferred Annual Bonus Plan




Period of return:


From:


1 November 2020 


To:


30 April 2021 




Balance of unallotted securities under scheme(s) from previous return:


0




Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):


300,000




Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):


264,481




Equals:  Balance under scheme(s) not yet issued/allotted at end of period:


35,519




 
 
 
 




Name of applicant:


GlaxoSmithKline plc




Name of scheme:


GlaxoSmithKline plc Share Save Plan 2012




Period of return:


From:


1 November 2020  


To:


30 April 2021




Balance of unallotted securities under scheme(s) from previous return:


1,277,629




Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):


360,000




Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):


1,255,163




Equals:  Balance under scheme(s) not yet issued/allotted at end of period:


382,466




 
The following GlaxoSmithKline plc Employee Share Schemes have expired and therefore will no longer be included in GlaxoSmithKline plc's Block Listing Six Monthly Returns: 
 
·    GlaxoSmithKline plc 2009 Deferred Annual Bonus Plan
 
·    GlaxoSmithKline 2009 Share Option Plan - Ordinary Shares
 
·    GlaxoSmithKline 2009 Share Option Plan - ADS
 




Name of contact:


Victoria Whyte




Telephone number of contact:


020 8047 5000




 
 
 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
BLRDZGMKZRKGMZM